NCT04908176 2024-12-13A Drug-drug Interaction Study of Avapritinib and MidazolamBlueprint Medicines CorporationPhase 1 Completed10 enrolled
NCT04714086 2024-10-24Expanded Access Program for AvapritinibBlueprint Medicines CorporationNo longer available
NCT02571036 2023-12-13A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesDeciphera Pharmaceuticals, LLCPhase 1 Completed282 enrolled
NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts